• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活物抑制剂-1基因4G/5G多态性与妊娠高血压综合征发病机制的关系

[Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].

作者信息

Guan Li-xue, Du Xin-ying, Wang Jing-xian, Wang Rui-li, Wu Zhen-lan, Jiang Hong

机构信息

Department of Genetics, Weifang People's Hospital, Weifang, Shandong, 261041 PR China.

出版信息

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Apr;21(2):173-5.

PMID:15079805
Abstract

OBJECTIVE

To investigate the relationship between a single nucleotide insertion/deletion(4G/5G) polymorphism located in the promoter region of the plasminogen activator inhibitor-1(PAI-1) gene and the pathogenesis of pregnancy-induced hypertension syndrome(PIHs).

METHODS

The 4G/5G polymorphism of PAI-1 gene in 171 PIHs patients (PIHs group) and that in 193 normal pregnant women (control group) were detected by a combination of polymerase chain reaction-restriction fragment length polymorphism.

RESULTS

(1)The genotype frequencies of PAI-1 gene in PIHs group were 47.4% for 4G/4G, 41.5% for 4G/5G, and 11.1% for 5G/5G. The 4G/4G genotype and 4G allele frequencies of PAI-1 gene(47.4% and 0.681) for PIHs patients were higher than those (21.2% and 0.495) for normal controls respectively (P<0.001). (2)Both the 4G/4G genotype and the 4G allele of PAI-1 gene occurred more frequently in the severe PIHs group(61.3% and 0.758) than those (35.8% and 0.623) in the mild PIHs group respectively (P<0.001). However, there were no significant differences between those in mild group (35.8% and 0.623) and moderate group(42.8% and 0.625) respectively. (3) The 4G/4G genotype was significantly associated with PIHs (OR=3.34, 95%CI: 2.14-5.22).

CONCLUSION

These findings suggested that PAI-1 gene polymorphism may be a susceptible factor to the pathogenesis of PIHs and the 4G/4G genotype may be one of the major risk factors for PIHs in pregnant women.

摘要

目的

探讨纤溶酶原激活物抑制剂-1(PAI-1)基因启动子区单核苷酸插入/缺失(4G/5G)多态性与妊娠高血压综合征(PIHs)发病机制之间的关系。

方法

采用聚合酶链反应-限制性片段长度多态性联合检测法,检测171例PIHs患者(PIHs组)和193例正常孕妇(对照组)PAI-1基因的4G/5G多态性。

结果

(1)PIHs组PAI-1基因的基因型频率为:4G/4G型占47.4%,4G/5G型占41.5%,5G/5G型占11.1%。PIHs患者PAI-1基因的4G/4G基因型频率(47.4%)和4G等位基因频率(0.681)分别高于正常对照组(21.2%和0.495)(P<0.001)。(2)PAI-1基因的4G/4G基因型和4G等位基因在重度PIHs组(61.3%和0.758)中出现的频率分别高于轻度PIHs组(35.8%和0.623)(P<0.001)。然而,轻度组(35.8%和0.623)与中度组(42.8%和0.625)之间无显著差异。(3)4G/4G基因型与PIHs显著相关(OR=3.34,95%CI:2.14-5.22)。

结论

这些研究结果表明,PAI-1基因多态性可能是PIHs发病机制的一个易感因素,4G/4G基因型可能是孕妇PIHs的主要危险因素之一。

相似文献

1
[Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].纤溶酶原激活物抑制剂-1基因4G/5G多态性与妊娠高血压综合征发病机制的关系
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Apr;21(2):173-5.
2
[Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].纤溶酶原激活物抑制剂-1基因和5,10-亚甲基四氢叶酸还原酶基因的遗传多态性与复发性早期自然流产的相关性
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Jun;22(3):330-3.
3
Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.纤溶酶原激活物抑制剂-1启动子基因多态性与心肌梗死的关系
Chin Med J (Engl). 2001 Mar;114(3):266-9.
4
4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.深静脉血栓形成患者PAI-1基因启动子4G/5G多态性与纤溶能力
Thromb Haemost. 1998 Dec;80(6):956-60.
5
[The study of PAI-1 promotor region gene polymorphism in cerebrovascular disease].[脑血管疾病中纤溶酶原激活物抑制剂-1启动子区域基因多态性的研究]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001 Oct;18(5):383-7.
6
The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia.纤溶酶原激活物抑制剂-1基因的4G/5G多态性与重度子痫前期相关。
J Hum Genet. 2000;45(3):138-41. doi: 10.1007/s100380050200.
7
[Relationship between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province].[广东省汉族2型糖尿病肾病患者纤溶酶原激活物抑制剂-1基因4G/5G多态性与2型糖尿病肾病的关系]
Di Yi Jun Yi Da Xue Xue Bao. 2004 Aug;24(8):904-7.
8
The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.纤溶酶原激活物抑制剂-1(PAI-1)基因启动子区的4G/5G序列多态性:与静脉血栓栓塞症患者血浆PAI-1水平的关系
Thromb Haemost. 1998 May;79(5):975-9.
9
[Association of genetic polymorphism in plasminogen activator inhibitor-1 gene with endometrial hypoplasia in infertile women].纤溶酶原激活物抑制剂-1基因多态性与不孕女性子宫内膜发育不全的相关性研究
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Aug;25(4):462-4.
10
[Genetic variations in plasminogen activator inhibitor-1 gene and beta fibrinogen gene associated with glomerular microthrombosis in lupus nephritis and the gene dosage effect].[纤溶酶原激活物抑制剂-1基因和β纤维蛋白原基因的遗传变异与狼疮性肾炎肾小球微血栓形成及基因剂量效应]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Feb;19(1):1-5.

引用本文的文献

1
Association of plasminogen activator inhibitor-type 1 (-675 4G/5G) polymorphism with pre-eclampsia: systematic review.纤溶酶原激活物抑制剂-1(-675 4G/5G)多态性与子痫前期的相关性:系统评价。
PLoS One. 2013;8(2):e56907. doi: 10.1371/journal.pone.0056907. Epub 2013 Feb 15.